Type(s) of chemotherapy-Single drug-Irinotecan (Campto) Posts on Medivizor
Navigation Menu

Type(s) of chemotherapy-Single drug-Irinotecan (Campto) Posts on Medivizor

Cetuximab combined with irinotecan improves the outcomes of patients with advanced colorectal cancer

Cetuximab combined with irinotecan improves the outcomes of patients with advanced colorectal cancer

Posted by on Dec 20, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of irinotecan (Camptosar) with and without cetuximab (Erbitux) in the treatment of metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that combined treatment improves the outcomes of these patients. Some background Colorectal cancer (CRC) is one of...

Read More

Searching for patients with advanced colorectal cancer to test a new T-cell treatment

Posted by on May 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 2 trial will investigate the effectiveness of genetically-engineered cell treatment (GECT) in advanced cancer.  The main outcome will be the response to treatment. This trial is recruiting at the National Cancer Institute, Maryland, US.  The details There are limited treatment options for advanced cancer. One...

Read More

Panitumumab combined with irinotecan as a treatment for metastatic colorecatal cancer without KRAS mutations

Panitumumab combined with irinotecan as a treatment for metastatic colorecatal cancer without KRAS mutations

Posted by on Apr 7, 2013 in Colorectal cancer | 0 comments

In a nutshell This study looks at the use of panitumumab and irinotecan as a combination treatment in patients with KRAS wild-type (non-mutated) metastatic colorectal cancer which has continued to progress while on standard chemotherapy (oxaliplatin, fluoropyrimidines, irinotecan, bevacizumab).   Some background Cancer cells can have...

Read More